West Pharmaceutical Services on LinkedIn: #onewestteam www.linkedin.com 查看2 条更新 总部 Exton, PA 公司盈利 13 亿至 68 亿(新元) 员工 10,000人以上 行业性质 醫療保健產品製造 查找另一家公司 搜索
Recognizing that safety transcends mere compliance,West Pharmaceutical Services(West) has embedded it into the core of its corporate values, ensuring that every team member, from the boardroom to the production floor, is an active participant in creating a hazard-free workplace. Their efforts have...
EXTON, Pa., Feb. 2, 2023 /PRNewswire/ --West Pharmaceutical Services, Inc.(NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2022 financi...
West Pharmaceutical Services Inc的平均EV/EBIT(5年)排名为第40.7x名,处于板块内95.1%的水平。下表提供了更多数据的摘要: 板块医疗保健的平均EV/EBIT(5年) 经济风险区类别 发达 全部成分股 2,509 包括的成分股 2,409 分钟 -141.3x 最大值 128.2x 中位数 -3.6x 平均值 -1.7x 标准差 26.4x 用本选股器选...
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the ...
We help you address challenges around the digitization of your business and investing in infrastructure in order to accelerate the introduction of new digital services and realize value faster. Solution providers can be slow to modernize toward true cloud-native benefits such as interoperability, decreas...
Pankit works with pharmaceutical and medical technology leaders to drive growth and innovation, operational improvement, and winning product strategies. Beth creates and executes strategic growth programs and product launches that transform business models, increase revenue, and capture new markets. ...
West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2023 and updated full-year 2023 financial guidance.
West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2023, updated full-year 2023 financial guidance and declared a fourth-quarter 2023 dividend.
Pharmaceutical companies are undergoing a digital transformation. By experimenting with new initiatives, they are positioned to play a role in the revolution of healthcare. This transformation is driven by data from internal and external sources, including both -omic data and that from digital devices...